Patient Perspectives Throughout Peri-Implantitis Treatment
ConditionPeri-implantitis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Barcelona
About this trial
To evaluate longitudinal changes in oral health-related quality of life (OHRQoL) and other patient-reported outcomes (PROMs) throughout the different stages of peri-implantitis therapy, including diagnosis, non-surgical treatment, surgical treatment, and 6-month follow-up. Secondarily, to explore the influence of clinical, implant-related, and surgical factors on patient-reported outcomes and treatment experience.
Eligibility criteria
Qualifiers
Adults (≥18 years) diagnosed with peri-implantitis according to the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions (Berglundh et al., 2018).
Implants presenting bleeding on probing (BoP) and/or suppuration on probing (SoP), increased probing depth, and progressive bone loss compared with previous records.
Disqualifiers
Patients who, following non-surgical peri-implantitis treatment, present ≤1 site with isolated bleeding on probing, no suppuration on probing, probing depths ≤5 mm, and no progressive bone loss compared with pretreatment bone levels.
Contraindications to surgical peri-implantitis treatment, including plaque index >20% and bleeding on probing >10%.
Previous radiotherapy to the head and neck region.
Uncontrolled diabetes mellitus/hyperglycaemia (HbA1c >7%).
Trial design
Treatments tested in this trial
- Not listed
Trial groups
45 Participants
are grouped into 1 trial groupSponsors and collaborators
University of Barcelona
Lead sponsor
Universitat Internacional de Catalunya
Collaborator
Universitat de Valencia, España
Collaborator
Source ClinicalTrials.gov